VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Tuesday, December 30, 2025
Stock Comparison
Bio-Rad Laboratories, Inc. vs Hims & Hers Health, Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Bio-Rad Laboratories, Inc.
BIO · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Bio-Rad Laboratories, Inc.'s moat claims, evidence, and risks.
View BIO analysisHims & Hers Health, Inc.
HIMS · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Hims & Hers Health, Inc.'s moat claims, evidence, and risks.
View HIMS analysisComparison highlights
- Moat score gap: Bio-Rad Laboratories, Inc. leads (61 / 100 vs 51 / 100 for Hims & Hers Health, Inc.).
- Segment focus: Bio-Rad Laboratories, Inc. has 2 segments (59.9% in Clinical Diagnostics); Hims & Hers Health, Inc. has 2 segments (97.4% in Online Platform).
- Primary market structure: Oligopoly vs Competitive. Pricing power: Moderate vs Moderate.
- Moat breadth: Bio-Rad Laboratories, Inc. has 6 moat types across 3 domains; Hims & Hers Health, Inc. has 3 across 2.
Primary market context
Bio-Rad Laboratories, Inc.
Clinical Diagnostics
In vitro diagnostics test systems, reagents/test kits, informatics, and clinical laboratory quality controls
Global
Hospital laboratories; diagnostic reference laboratories; transfusion laboratories; physician office laboratories
IVD OEM / installed-base consumables supplier (systems + kits + controls)
59.9%
Hims & Hers Health, Inc.
Online Platform
Direct-to-consumer telehealth + subscription pharmacy (cash-pay) for lifestyle and chronic conditions
Primarily United States
Consumers (end-users), paid out-of-pocket; supported by affiliated provider networks and pharmacy fulfillment
D2C digital health platform + fulfillment (mail-order pharmacy and partners)
97.4%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
Bio-Rad Laboratories, Inc. strengths
Hims & Hers Health, Inc. strengths
Segment mix
Bio-Rad Laboratories, Inc. segments
Full profile >Life Science
Competitive
Clinical Diagnostics
Oligopoly
Hims & Hers Health, Inc. segments
Full profile >Online Platform
Competitive
Wholesale
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.